The client, with an established national field sales footprint, looked to partner to improve the stagnant sales trajectory for their I/O delivery device.
A field team of 16 DSAs (diabetes representatives) was overlayed to existing team to support high and medium-value targets to improve impact and call frequency.
DSAs’ goals also included elevating brand perception not just to the targeted HCPs but through a total account call to maximize pull-through adjacent to clinical selling.
Within the first four months of the added team, high-value DSA targets were averaging 3.5 more Rxs per target compared to the control group.
Average DSA had 21% more call activity (and 12% more sampling) than incumbent team.
Call activity (reach and frequency) was improved while contributing to a significant improvement in the cost per call (82% savings) for DSA targets.
Qualitative (market effectiveness surveys) feedback also showed improved brand and message recall and DSA satisfaction.
Wave 1:
93% of respondents state that they are ‘very satisfied’ with their DSA.**
**7% state that they are ‘satisfied’.
Jump to a slide with the slide dots.
Wie intelligente Außendienstmodelle, KI und Customer Experience als Gestaltungsprinzip HCP-Journeys relevanter machen
Weiterlesen
Discover how learning systems, AI, and continuous optimisation are transforming pharmaceutical commercial strategy and HCP engagement.
Weiterlesen
Erfahren Sie, wie Inizio Engage ein skalierbares Modell für die Apothekenkommunikation in Deutschland entwickelte, über 3.500 Apotheken erreichte...
Weiterlesen